Silver Book Fact
Negative value of antibiotics to drug companies
The value of an antibiotic to a drug company is negative $50 million- compared to the positive value of $1 billion for a new musculoskeletal drug.
Incentives for R&D for New Antimicrobial Drugs: Research paper 11/02. http://www.ohe.org/publications/article/incentives-for-rd-for-new-antimicrobial-drugs-7.cfm. Published 2011